Literature DB >> 7042770

Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation.

W M Petrie, T A Ban, S Berney, M Fujimori, W Guy, M Ragheb, W H Wilson, J D Schaffer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042770

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  12 in total

Review 1.  Neuropsychiatric aspects of Alzheimer's disease.

Authors:  C Ballard; M Walker
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

Review 2.  Behavioural problems associated with dementia: the role of newer antipsychotics.

Authors:  G Stoppe; C A Brandt; J H Staedt
Journal:  Drugs Aging       Date:  1999-01       Impact factor: 3.923

Review 3.  Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia.

Authors:  M E Hemels; K L Lanctôt; M Iskedjian; T R Einarson
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 4.  Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience.

Authors:  Sandra S Kindermann; Christian R Dolder; Anne Bailey; Ira R Katz; Dilip V Jeste
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 5.  New atypical antipsychotics. Experience and utility in the elderly.

Authors:  R A Sweet; B G Pollock
Journal:  Drugs Aging       Date:  1998-02       Impact factor: 3.923

Review 6.  A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.

Authors:  M Zaudig
Journal:  Drug Saf       Date:  2000-09       Impact factor: 5.606

Review 7.  Monoamine neurons in aging and Alzheimer's disease.

Authors:  A M Palmer; S T DeKosky
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 8.  Antipsychotics in older patients. A safety perspective.

Authors:  B G Pollock; B H Mulsant
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

9.  Unmet Needs in Pharmacological Treatment of Apathy in Alzheimer's Disease: A Systematic Review.

Authors:  Christos G Theleritis; Kostas T Siarkos; Antonios M Politis
Journal:  Front Pharmacol       Date:  2019-10-04       Impact factor: 5.810

10.  Subjective Versus Objective Outcomes of Antipsychotics for the Treatment of Neuropsychiatric Symptoms Associated with Dementia.

Authors:  Eline J Vredeveld; Tessa A Hulshof; Sytse U Zuidema; Hendrika J Luijendijk
Journal:  CNS Drugs       Date:  2019-09       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.